None listed
Conditions
Interventions
Intervention1: Product 1-ZB-64
Product 2-ZB-87
Product 3-ZB-94
Product 4-MPB-22
: The 40 microliterof each products will be loaded in IQ Chambers of patch and the same will be pasted on upper back of
Sponsors
Emami ltd
Eligibility
Inclusion criteria
Inclusion criteria: • Subjects age group 18-55 years • Healthy male & female volunteers • Subjects with skin type III to V. • Subjects willing to give a written informed consent. • Subjects willing to maintain the patch test in position for 24 hours • Subject has not participated in a similar investigation in the past two weeks. • Subjects willing to come for regular follow up. • Subjects ready to follow instructions during the study period.
Exclusion criteria
Exclusion criteria: • Infection, allergy on the test site • Skin allergy antecedents or atopic subjects • Hyper sensitivity to any component of the tested products • Athletes and subjects with history of excessive sweating • Cutaneous disease which may influence the study result • Chronic illness which may influence the cutaneous state. • Subjects on oral corticosteroid with dose >10mg/day • Subjects participating in any other cosmetic or therapeutic trial. • Any history of underlying uncontrolled medical illness including diabetes, hypertension, liver disease or history of alcoholism, HIV or any other serious medical illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The objective of this study is to evaluate the dermatological safety of the given investigational products on healthy human volunteers.Timepoint: The objective of this study is to evaluate the dermatological safety of the given investigational products on healthy human volunteers. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Mukesh Ramnane
MS Clinical Research Pvt.Ltd
Outcome results
None listed